Commentaires de nos clients
Search:
Perform search
Liste des catégories

Générique Fenofibrate - Tricor

News
Recherche par lettre:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Tricor
Tricor Générique est utilisé pour contrôler les niveaux élevés de cholestérol et de triglycérides dans le sang. Il est utilisé en combinaison avec une alimentation faible en cholestérol et en graisses saturées. Le Tricor Générique est un agent régulateur de lipides. Il diminue les niveaux élevés de triglycérides dans le sang en poussant le foie à produire moins de triglycérides et à éliminer plus de triglycérides de la circulation sanguine.
€1.00
Bookmarks sociaux
Choose your language:



Remboursementgaranti
Achatsécurisé

Notre page de facturation est certifiée par:

Secure shopping certificates

Special Offer!

  • Treatment of chronic hemodialysis patients with low-dose fenofibrate ... - 7thSpace Interactive (press release)

    Treatment of chronic hemodialysis patients with low-dose fenofibrate .

  • Impax cited by FDA in manufacturing inspection - FierceDrugDelivery

    Impax cited by FDA in manufacturing inspectionFierceDrugDeliveryThe company was cited last year for issues related to the production of fenofibrate, a high cholesterol treatment, resulting in a recall of 5 lots of the drug, FiercePharmaManufacturing reported.

  • Expect strong growth from US in FY13-14 - Moneycontrol.com

    Expect strong growth from US in FY13-14Moneycontrol.

  • Veloxis Restructures to Focus on Late-Stage Once-Daily Immunosuppressant - Genetic Engineering News

    Veloxis Restructures to Focus on Late-Stage Once-Daily ImmunosuppressantGenetic Engineering NewsApart from LCP-Tacro, the firm's clinical pipeline includes the Phase II- and III-ready cardiovascular products AtorFen™, a fixed-dose combination tablet of fenofibrate and atorvastatin, and LCP-Feno™, a generic fenofibrate tablet formulation.

  • Webcast - Q1 Earnings Announcement - Canada NewsWire (press release)

    Webcast - Q1 Earnings AnnouncementCanada NewsWire (press release)The Company's first product is a fenofibrate formulation marketed in the United States as Lipofen®.

    Copyright © 2005-2010 Canadian Pharmacy Online Canada Pharmacy, Canadian Pharmacy.